Cargando…

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years

BACKGROUND: Despite modern intensive care with standardized strategies against acute respiratory distress syndrome (ARDS), Pneumocystis pneumonia (PcP) remains a life-threatening disease with a high mortality rate. Here, we analyzed a large mixed cohort of immunocompromised patients with PcP, with r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Julius J., Lueck, Catherina, Ziesing, Stefan, Stoll, Matthias, Haller, Hermann, Gottlieb, Jens, Eder, Matthias, Welte, Tobias, Hoeper, Marius M., Scherag, André, David, Sascha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245758/ https://www.ncbi.nlm.nih.gov/pubmed/30454031 http://dx.doi.org/10.1186/s13054-018-2221-8

Ejemplares similares

“Better be awake”—a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia
por: Stahl, Klaus, et al.
Publicado: (2019)

Corrigendum to: Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic
por: Stahl, Klaus, et al.
Publicado: (2020)

Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic
por: Stahl, Klaus, et al.
Publicado: (2019)

Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients
por: Baier, Claas, et al.
Publicado: (2019)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022)

Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?
por: Aguilar, Yudy A., et al.
Publicado: (2021)

Extracorporeal membrane oxygenation in non-intubated immunocompromised patients
por: Stahl, Klaus, et al.
Publicado: (2021)

Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
por: LONG, YINGJIAO, et al.
Publicado: (2014)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
por: Lueck, Catherina, et al.
Publicado: (2022)

Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock
por: Stahl, Klaus, et al.
Publicado: (2020)

Staying Awake in Severe Acute Respiratory Distress Syndrome: A Perspective on Immunocompromised Patients
por: Stahl, Klaus, et al.
Publicado: (2021)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients
por: Sarasombath, Patsharaporn T., et al.
Publicado: (2021)

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
por: Cao, Yaoqian, et al.
Publicado: (2022)

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
por: Bezzina, Alastair David, et al.
Publicado: (2022)

Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19
por: Stahl, Klaus, et al.
Publicado: (2020)

Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients
por: Wang, Dong, et al.
Publicado: (2017)

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

Pneumocystis Pneumonia in a Non-Immunocompromised Lung Cancer Patient after Surgery: A Case Report
por: Kim, Tae-Woo, et al.
Publicado: (2022)

Evaluation of Loop-Mediated Isothermal Amplification Assay for the Detection of Pneumocystis jirovecii in Immunocompromised Patients
por: Singh, Preeti, et al.
Publicado: (2015)

Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
por: Gioia, Francesca, et al.
Publicado: (2022)

AN UNEXPECTED RECURRENCE: A CASE OF PNEUMOCYSTIS JIROVECI AND SARS-COV-2 IN AN IMMUNOCOMPROMISED PATIENT
por: PALACIOS, CARLOS, et al.
Publicado: (2022)

Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia
por: Zhang, Nan-Nan, et al.
Publicado: (2019)

Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing
por: Duan, Jiali, et al.
Publicado: (2022)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
por: Ibrahim, Atif, et al.
Publicado: (2023)

Integrated multi-omics analyses reveal the altered transcriptomic characteristics of pulmonary macrophages in immunocompromised hosts with Pneumocystis pneumonia
por: Wang, Yawen, et al.
Publicado: (2023)

Molecular characterization and improved diagnostics of Nocardia strains isolated over the last two decades at a German tertiary care center
por: Chhatwal, Patrick, et al.
Publicado: (2021)

Pneumocystis Pneumonia in HIV-Infected and Immunocompromised Non-HIV Infected Patients: A Retrospective Study of Two Centers in China
por: Guo, Fei, et al.
Publicado: (2014)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia
por: Huang, L.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mjj4uaot4eq850qk54obhqkmqs